3B BlackBio Dx (BOM:532067) Debt-to-Equity : N/A (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx Debt-to-Equity?

3B BlackBio Dx's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. 3B BlackBio Dx's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. 3B BlackBio Dx's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for 3B BlackBio Dx's Debt-to-Equity or its related term are showing as below:

BOM:532067' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.29 Max: 0.78
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of 3B BlackBio Dx was 0.78. The lowest was 0.01. And the median was 0.29.

BOM:532067's Debt-to-Equity is ranked better than
99.91% of 1074 companies
in the Biotechnology industry
Industry Median: 0.15 vs BOM:532067: 0.01

3B BlackBio Dx Debt-to-Equity Historical Data

The historical data trend for 3B BlackBio Dx's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx Debt-to-Equity Chart

3B BlackBio Dx Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.28

0.11

0.02

0.01

3B BlackBio Dx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.01	N/A	0.01	N/A

Competitive Comparison of 3B BlackBio Dx's Debt-to-Equity

For the Biotechnology subindustry, 3B BlackBio Dx's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3B BlackBio Dx's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's Debt-to-Equity falls into.

3B BlackBio Dx Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

3B BlackBio Dx's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.157	+	9.134)	/	1712.262
	=	0.01

3B BlackBio Dx's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

3B BlackBio Dx (BOM:532067) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

3B BlackBio Dx Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

3B BlackBio Dx (BOM:532067) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023

Website

https://www.3bblackbio.com

3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines